BHST · BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. announced a strategic leadership transition effective April 29, 2026, designed to sharpen execution of its 'two-lens strategy' across its direct-to-consumer (D2C) and Contract Development and Manufacturing Organization (CDMO) businesses. Dr. Zaki Rakib, the Company's Co-Founder and Executive Chairman, has assumed the role of Chief Executive Officer, consolidating leadership of R&D, Manufacturing, and Operations in the CDMO division under a unified structure. Ilan Sobel, who served as CEO since 2020, has transitioned from his executive role and has been appointed to the Board of Directors, where he will focus on advancing the D2C business. Dr. Rakib brings more than 35 years of executive leadership experience and deep institutional knowledge of BioHarvest's technology platform. He previously co-founded and led Terayon Communication Systems from inception to $380 million in annual revenue and a $7 billion market capitalization as a Nasdaq-listed company within six years. Mr. Sobel's tenure as CEO saw BioHarvest grow from a pre-revenue operation to approximately $35 million in revenue in fiscal year 2025, establishing the Company as a fully operational, Nasdaq-listed growth platform. The Board expressed appreciation for Mr. Sobel's contributions and looks forward to his continued expertise as a director.